Tag: oral contraceptive pills market drivers

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Oral Contraceptive Pills Market Evolve in Terms of Growth and Size by 2029?

The dimension of the oral contraceptive pills market has seen tremendous growth in the past few years. The market is predicted to expand from $26.82 billion in 2024 to $30.43 billion in 2025, marking a compound annual growth rate (CAGR) of 13.5%. The considerable growth observed during the historic period can be credited to factors such as improved awareness, escalating concerns about women’s health, initiatives by the government, alterations in lifestyle patterns, and market broadening.

The market size for oral contraceptive pills is predicted to undergo significant expansion in the upcoming years and is set to reach “$53.07 billion by 2029, witnessing a compound annual growth rate (CAGR) of 14.9%.” Factors contributing to this projected growth during the predicted period include a growing population, the empowerment of women, increased healthcare spending, improvements in healthcare infrastructure, and a broadening product range. The forecast period also sees trends focusing on reducing side effects and hormonal imbalances, the arrival of natural and non-hormonal contraceptive alternatives, a shift to continuous and customized contraceptive plans, intensifying education and awareness initiatives, and a surge in female engagement and decision-making in contraceptive choices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

What factors are expected to fuel Oral Contraceptive Pills market growth in the coming years?

The prevalence of unplanned pregnancies is anticipated to bolster the expansion of the oral contraceptive pills market in the forthcoming years. An unplanned pregnancy refers to one that has not been desired, such as instances where no children were planned. A study conducted by the University of California, San Francisco (UCSF) revealed that the turnout of unwanted pregnancies and abortion significantly dropped when women were given a year-long prescription of oral contraceptive pills. The World Health Organization (WHO) reports suggest that there are 74 million women in low to middle-income countries recording unplanned pregnancies annually across the world. Upon observation, the WHO discovered that 4,794 women experienced unplanned pregnancies after they stopped using contraceptive measures. As such, the requirement to evade unintended pregnancies propels the growth of the oral contraceptive pills market.

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

What Are The Leading Trends And Opportunities In The Oral Contraceptive Pills Sector?

Significant organizations and corporations in the oral contraceptive pill industry are concentrating on the creation of innovative solutions for oral contraceptive pills. For illustration, the United Kingdom initiated clinical trials in December 2023 for a contraceptive pill devoid of male hormones. This precedent-setting trial marks the research team in the nation as a global frontrunner in the study of this revolutionary drug type. The drug in focus is YCT-529, which acts as a retinoic acid receptor-alpha suppressor. Its functioning model halts sperm production by restricting the availability of vitamin A. The drug’s invention is credited to a research team from the University of Minnesota in Minneapolis.

What Are The Most Active Companies In The Oral Contraceptive Pills Market Today?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Which Regional Markets Are Attracting The Most Investment In Oral Contraceptive Pills?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Oral Contraceptive Pills Market Evolve in Terms of Growth and Size by 2029?

The dimension of the oral contraceptive pills market has seen tremendous growth in the past few years. The market is predicted to expand from $26.82 billion in 2024 to $30.43 billion in 2025, marking a compound annual growth rate (CAGR) of 13.5%. The considerable growth observed during the historic period can be credited to factors such as improved awareness, escalating concerns about women’s health, initiatives by the government, alterations in lifestyle patterns, and market broadening.

The market size for oral contraceptive pills is predicted to undergo significant expansion in the upcoming years and is set to reach “$53.07 billion by 2029, witnessing a compound annual growth rate (CAGR) of 14.9%.” Factors contributing to this projected growth during the predicted period include a growing population, the empowerment of women, increased healthcare spending, improvements in healthcare infrastructure, and a broadening product range. The forecast period also sees trends focusing on reducing side effects and hormonal imbalances, the arrival of natural and non-hormonal contraceptive alternatives, a shift to continuous and customized contraceptive plans, intensifying education and awareness initiatives, and a surge in female engagement and decision-making in contraceptive choices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

What factors are expected to fuel Oral Contraceptive Pills market growth in the coming years?

The prevalence of unplanned pregnancies is anticipated to bolster the expansion of the oral contraceptive pills market in the forthcoming years. An unplanned pregnancy refers to one that has not been desired, such as instances where no children were planned. A study conducted by the University of California, San Francisco (UCSF) revealed that the turnout of unwanted pregnancies and abortion significantly dropped when women were given a year-long prescription of oral contraceptive pills. The World Health Organization (WHO) reports suggest that there are 74 million women in low to middle-income countries recording unplanned pregnancies annually across the world. Upon observation, the WHO discovered that 4,794 women experienced unplanned pregnancies after they stopped using contraceptive measures. As such, the requirement to evade unintended pregnancies propels the growth of the oral contraceptive pills market.

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

What Are The Leading Trends And Opportunities In The Oral Contraceptive Pills Sector?

Significant organizations and corporations in the oral contraceptive pill industry are concentrating on the creation of innovative solutions for oral contraceptive pills. For illustration, the United Kingdom initiated clinical trials in December 2023 for a contraceptive pill devoid of male hormones. This precedent-setting trial marks the research team in the nation as a global frontrunner in the study of this revolutionary drug type. The drug in focus is YCT-529, which acts as a retinoic acid receptor-alpha suppressor. Its functioning model halts sperm production by restricting the availability of vitamin A. The drug’s invention is credited to a research team from the University of Minnesota in Minneapolis.

What Are The Most Active Companies In The Oral Contraceptive Pills Market Today?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Which Regional Markets Are Attracting The Most Investment In Oral Contraceptive Pills?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Oral Contraceptive Pills Market, and What Factors Will Drive It?

The market for oral contraceptive pills has witnessed a substantial expansion in the past few years. It is projected to rise from a value of $26.82 billion in 2024 to $30.43 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.5%. Several factors contributed to the growth during the historic period, such as increasing awareness, growing concerns regarding women’s health, government initiatives, shifts in lifestyles, and overall market expansion.

Anticipations suggest a swift expansion in the market size of oral contraceptive pills in the forthcoming years, bolstering it to reach $53.07 billion by 2029 at a compound annual growth rate (CAGR) of 14.9%. The projected growth in this period can be linked to factors such as an increasing population, the empowerment of women, a surge in healthcare spending, advancements in the health care infrastructure, and a broadening product array. Key trends during this timeframe point towards a focus on diminishing side effects and hormonal imbalance, the advent of non-hormonal and natural alternatives to contraception, a shift towards continuous and tailored contraceptive protocols, a rise in awareness and education initiatives and a surge in the role and empowerment of women in contraceptive decision-making.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Oral Contraceptive Pills Market?

The substantial number of accidental pregnancies is anticipated to fuel the expansion of the oral contraceptive pills market in the imminent years. An accidental pregnancy refers to one that is not planned for or desired, for instance, where a child or children weren’t part of the plan. According to a study conducted by The University of California, San Francisco (UCSF), it is seen that the rates of undesired pregnancies and abortions significantly decreased when women were given a yearly prescription of oral contraceptive pills. The World Health Organization (WHO) reports that every year, as many as 74 million women in low-middle income economies end up with unanticipated pregnancies across the globe. The research conducted by WHO noticed that 4,794 women ended up with unplanned pregnancies post discontinuation of contraceptive usage. Hence, the desire to circumvent accidental pregnancies promotes the growth of the oral contraceptive pills market.

Which Primary Segments of the Oral Contraceptive Pills Market Are Driving Growth and Industry Transformations?

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Oral Contraceptive Pills Market?# Market?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Oral Contraceptive Pills Market?

Various leading organizations and corporations within the oral contraceptive pill sector are concentrating on creating novel solutions for these pills. For example, in December 2023, The United Kingdom started clinical trials for an innovative contraception pill that does not involve male hormones. This pioneering trial positions the research community in the nation as a global front-runner in exploring this new kind of drug. The drug under consideration, YCT-529, functions as a retinoic acid receptor-alpha blocker. This treatment impedes sperm production by obstructing the availability of vitamin A. The medication was developed by a research group at the University of Minnesota, Minneapolis.

View the full report here:

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

What Parameters Are Used to Define the Oral Contraceptive Pills Market?

Oral contraceptive pills refer to a contraceptive tablet that contains hormones that prevent the release of eggs from the ovaries. Oral contraceptives typically contain progestin and estrogen. Also known as the birth control pill it comprises hormones that prevent the emergence of eggs from the ovaries. Most oral contraceptives involve estrogen and progestin.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3900

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Oral Contraceptive Pills Market?

The market for oral contraceptive pills has seen a significant surge in its size in the past few years. The size of this market is forecasted to increase from $26.82 billion in 2024 to $30.7 billion in 2025, implying a CAGR of 14.5%. The factors attributing to the growth during the historic period include increased awareness, growing concerns about women’s health, initiatives by the government, shifts in lifestyle, and market expansion.

What Growth Rate Is Forecasted for the Oral Contraceptive Pills Market by 2029?

Expectations for the oral contraceptive pills market indicate a swift expansion in the coming years, with its worth expected to hit $54.21 billion in 2029, thanks to a compound annual growth rate (CAGR) of 15.3%. Factors contributing to this surge during the forecast period include population growth, women’s empowerment, increased healthcare spending, advancements in healthcare structure, and a broadened product range. Future trends include an emphasis on reducing side effects and hormonal disturbances, the introduction of non-hormonal and natural contraceptive alternatives, a shift towards uninterrupted and personalized contraceptive plans, increased awareness and education efforts, and a rise in women’s empowerment and decision-making in contraceptive selection.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

Which Key Companies Are Shaping the Future of the Oral Contraceptive Pills Market?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

Which Factors Are Driving Demand in the Oral Contraceptive Pills Industry?

The elevated occurrence of unplanned pregnancies is anticipated to fuel the expansion of the oral contraceptive pills market in future years. An unplanned pregnancy is one that is always undesired, such as when there’s no plan for any children. A study by the University of California, San Francisco (UCSF) revealed that the prevalence of unwanted pregnancies and abortions notably dropped when women were given a one-year prescription for oral contraceptives. The World Health Organization (WHO) reports that 74 million women in low to middle-income economies experience unplanned pregnancies annually worldwide. The study done by WHO noted that 4,794 women encountered unplanned pregnancies after they ceased usage of contraceptives. Consequently, the requirement to evade unplanned pregnancies is driving the growth of the oral contraceptive pills market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

How Is the Oral Contraceptive Pills Market Segmented by Several Divisions?

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

What are the Emerging Market Trends Driving the Growth of the Oral Contraceptive Pills Industry?

Prominent organizations and corporations in the oral contraceptive pill industry are concentrating on creating advanced solutions for oral contraceptive pills. For example, in December 2023, The United Kingdom initiated clinical trials for a male contraception pill which is free of hormones. This unprecedented trial situates the research team in the country as a worldwide pioneer in examining this novel class of drug. The drug, YCT-529, functions as a retinoic acid receptor-alpha inhibitor, disrupting sperm production by blocking access to vitamin A. The drug was developed by a group of scientists from the University of Minnesota in Minneapolis.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Which Regions Are Driving Growth in the Oral Contraceptive Pills Market?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3900

This Report Delivers Insight On:

1. How big is the oral contraceptive pills market, and how is it changing globally?

2. Who are the major companies in the oral contraceptive pills market, and how are they performing?

3. What are the key opportunities and risks in the oral contraceptive pills market right now?

4. Which products or customer segments are growing the most in the oral contraceptive pills market?

5. What factors are helping or slowing down the growth of the oral contraceptive pills market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Oral Contraceptive Pills Market?

The escalation in the occurrence of unplanned pregnancies is anticipated to fuel the expansion of the oral contraceptive pills market in the forthcoming years. Unintended pregnancies refer to those that are never desired, such as ones where no child has been planned for. A study from the University of California, San Francisco (UCSF) indicates that the frequencies of undesired pregnancies and abortion noticeably decreased when women were given a one-year prescription for oral contraceptives. The World Health Organization (WHO) states that annually, 74 million women from lower-middle-income economies around the globe experience unplanned pregnancies. Further research by the WHO observed 4,794 women having unexpected pregnancies post discontinuation of contraceptive usage. Hence, the necessity to prevent unintended pregnancies bolsters the growth of the oral contraceptive pills market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

#What Long-Term Growth Rate is Expected for theOral Contraceptive Pills Market Between 2025 and 2034?

The market for oral contraceptive pills has witnessed a swift expansion in the last few years, with predictions indicating a growth from $26.82 billion in 2024 to an estimated $30.7 billion in 2025, reflecting a compound annual growth rate (CAGR) of 14.5%. This significant growth in historical times can be credited to factors such as enhanced awareness, escalating concerns related to women’s health, government-backed initiatives, transformations in lifestyles, and general market proliferation.

In the upcoming years, a significant upward trend is projected in the oral contraceptive pills market, reaching a valuation of $54.21 billion by 2029 at a compound annual growth rate (CAGR) of 15.3%. Factors contributing to this growth during the forecasted period include an increasing population, women’s empowerment, increased healthcare spending, and advancements in the health infrastructure. Additionally, the broadening range of available products is also a driving factor. Key trends for the period include a focus on reducing side effects and hormonal imbalance, the emergence of natural and non-hormonal contraceptive alternatives, a shift towards personalized and continuous contraceptive regimens, initiatives to raise awareness and education, and a surge in female empowerment leading to their active participation in contraceptive choices.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3900

What Are the Key Market Innovations in theOral Contraceptive Pills Market Over the Coming Years?

Significant institutions and firms active in the oral contraceptive pill industry are prioritizing the creation of novel oral contraceptive solutions. For example, in December 2023, the United Kingdom launched clinical testing for a male contraception pill devoid of hormones. This pioneering study positions the UK research community as a global front-runner in the exploration of this new class of medication. The drug being examined, YCT-529, functions as a retinoic acid receptor-alpha inhibitor. This drug works by hinder sperm production through vitamin A blockage. This pharmaceutical was developed by a research team from the University of Minnesota in Minneapolis.

Who Are the Top Companies Driving Innovation and Growth in theOral Contraceptive Pills Market?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Which Key Market Segments Comprise the Oral Contraceptive Pills Market and Drive Its Revenue Growth?

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3900&type=smp

Which Regions Are Emerging as Leaders in the Oral Contraceptive Pills Market?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Oral Contraceptive Pills Market 2025, By The Business Research Company:

Transportation Manufacturing Global Market Report 2019

https://www.thebusinessresearchcompany.com/report/transportation-manufacturing-global-market-report

Truck Transportation Global Market Report 2019

https://www.thebusinessresearchcompany.com/report/truck-transportation-global-market-report

Passenger Air Transport Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/passenger-air-transport-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the oral contraceptive pills market size evolved in recent years?

In recent times, the market size for oral contraceptive pills has expanded swiftly. Expected to rise from $26.82 billion in 2024 to $30.7 billion in 2025, it will have a compound annual growth rate (CAGR) of 14.5%. Factors such as greater awareness, heightened focus on women’s health, government policies, lifestyle alterations, and market growth contributed to the growth during the historic period.

What are the predictions for the oral contraceptive pills market size in the coming years?

Get your oral contraceptive pills market report here!

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

What key factors are fueling the growth of the oral contraceptive pills market?

The anticipated rise in unplanned pregnancies is predicted to fuel the expansion of the oral contraceptive pills market in the near future. Unplanned pregnancies are those in which no aspect of conception or childbirth was deliberated or wanted. Research from the University of California, San Francisco (UCSF) demonstrates a significant drop in both unintended pregnancies and abortions when women were provided a year’s supply of oral contraceptive pills. The World Health Organization (WHO) reports that each year, 74 million women from low-middle-income countries account for unplanned pregnancies globally. An observation by the WHO revealed that 4,794 women had unplanned pregnancies upon stopping contraceptive use. Consequently, the necessity to prevent unplanned pregnancies propels the oral contraceptive pills market’s growth.

How is the global oral contraceptive pills market divided into key segments?

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channels

Subsegments:

1) By Combination Pills: Monophasic Combination Pills, Multiphasic Combination Pills, Extended-Cycle Combination Pills

2) By Progestin-Only Pills: Daily Progestin-Only Pills, Progestin-Only Emergency Contraceptive Pills

3) By Other Types: Low-Dose Oral Contraceptive Pills, High-Dose Oral Contraceptive Pills, Non-Hormonal Oral Contraceptives (In Development Or Alternative Formulations)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

Who are the key firms paving the way for growth in the oral contraceptive pills market?

Major companies operating in the oral contraceptive pills market include Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, Zydus Lifesciences Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., Mayne Pharma, HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, V Care Pharma

Which trends are expected to transform the oral contraceptive pills market?

Key players in the oral contraceptive pills market comprise Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Abbvie Inc., Bayer AG, and Zydus Lifesciences Ltd., to name a few. Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Cipla Inc., and Dr. Reddy’s Laboratories Ltd. are also in the industry, along with Amneal Pharmaceuticals LLC, Lupin Pharmaceuticals Inc., Glenmark Pharmaceuticals, Mankind Pharma Ltd., and Mayne Pharma. The market also includes HLL Lifecare Limited, Famy Care Ltd., Mylan N.V., Novartis AG, GlaxoSmithKline plc, Piramal Enterprises Ltd., Syzygy Healthcare, and V Care Pharma.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3900

What regions are contributing significantly to the growth of the oral contraceptive pills market?

North America was the largest region in the oral contraceptive pills market in 2024. The Middle East is expected to be the largest growing region in the forecast period. The regions covered in the oral contraceptive pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Cough And Cold Preparations Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cough-and-cold-preparations-global-market-report

Polycystic Ovarian Syndrome Treatment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/polycystic-ovarian-syndrome-treatment-global-market-report

Hormonal Contraceptives Global Market Opportunities And Strategies To 2030: COVID-19 Growth And Change

https://www.thebusinessresearchcompany.com/report/hormonal-contraceptives-market

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: